Orbo A
Gynekologisk onkologisk avsnitt Kvinneklinikken Regionsykehuset i Tromsø.
Tidsskr Nor Laegeforen. 1996 Oct 10;116(24):2886-8.
Tumour markers can be defined as biological changes indicating the existence of malignancy in the organism. After the development of monoclonal antibodies, an array of new tumor markers have been discovered over the last two decades. General guidelines are given for the use of tumour markers in practice. Finally, the markers of special relevance for gynecological oncology, and some other recently discovered markers are described.
